Leap Therapeutics Correlations

LPTX Stock  USD 2.98  0.06  2.05%   
The current 90-days correlation between Leap Therapeutics and X4 Pharmaceuticals is 0.12 (i.e., Average diversification). The correlation of Leap Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Leap Therapeutics Correlation With Market

Average diversification

The correlation between Leap Therapeutics and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Leap Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.

Moving together with Leap Stock

  0.69MOLN Molecular PartnersPairCorr

Moving against Leap Stock

  0.49ELAN Elanco Animal HealthPairCorr
  0.47ZTS Zoetis IncPairCorr
  0.34HLN Haleon plcPairCorr
  0.33MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.64CTLT CatalentPairCorr
  0.56ANRO Alto Neuroscience,PairCorr
  0.55CVS CVS Health Corp Sell-off TrendPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
HOOKXFOR
HOOKINZY
MREOINZY
TERNXFOR
INZYXFOR
HOOKMREO
  
High negative correlations   
ELEVPDSB
HEPADAWN
HEPAPDSB
EFTRDAWN
ELEVTERN

Risk-Adjusted Indicators

There is a big difference between Leap Stock performing well and Leap Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Leap Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
XFOR  5.02 (0.47) 0.00 (0.22) 0.00 
 8.82 
 62.35 
TERN  3.37 (0.33) 0.00 (0.22) 0.00 
 6.02 
 34.09 
DAWN  2.06 (0.09)(0.04) 0.01  2.77 
 3.84 
 11.44 
PDSB  3.37 (0.63) 0.00 (0.24) 0.00 
 7.67 
 31.83 
INZY  2.76 (1.22) 0.00 (0.59) 0.00 
 5.07 
 16.62 
EFTR  7.57 (5.30) 0.00 (0.79) 0.00 
 8.70 
 88.91 
ELEV  3.46 (0.37) 0.00 (0.05) 0.00 
 5.77 
 22.21 
MREO  2.72 (0.48) 0.00 (0.30) 0.00 
 4.80 
 17.36 
HEPA  3.78 (0.37) 0.00 (0.09) 0.00 
 8.06 
 33.54 
HOOK  2.81 (1.14) 0.00 (1.07) 0.00 
 6.85 
 22.98 

Leap Therapeutics Corporate Management